This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Cold Chain Packaging Market

Market Insights on Pharmaceutical Cold Chain Packaging covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical Cold Chain Packaging Market By Packaging Format(Passive Packaging, Active Packaging), Product(Small Boxes, Pallets), Material(Polymer, Metal), Application(Biologics and Biological Samples, Vaccines and Diagnostics), End-Use(Diagnostic Centers, Clinical Research Organization), & Region - Forecast 2021 - 2031

Pharmaceutical Cold Chain Packaging Market Snapshot

Newly released data by Future Market Insights (FMI) projects the global pharmaceutical cold chain packaging market to register a CAGR of ~15%, to reach US$ 46.9 Bn by 2031.

As per the report, polymer will emerge as the top-choice for packaging material and it is expected to account for over 62.1% of the global market share in 2021. It also is expected to attract an incremental opportunity of US$ 22.3 Bn through 2031.

The demand in the U.S. is expected to increase at a robust CAGR of 12.3%, sealing the country’s dominance in the North America pharmaceutical cold chain packaging market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in the Pharmaceutical Cold Chain Packaging Market Survey

  • Market Estimates and Forecast 2015-2031
  • Key Drivers and Restraints Impacting Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Pharmaceutical Cold Chain Packaging Market and How to Navigate
  • Recommendation on Key Winning Strategies

2016-2020 Pharmaceutical Cold Chain Packaging Market Outlook Compared to 2021-2031 Forecast

Future Market Insights has pegged the global pharmaceutical cold chain packaging market to expand at an impressive CAGR of 14.9% during 2021-2031, compared to 12.5% in 2015-2020. Growth registered in the market can be attributed to the increasing investment towards improved packaging solution to reduce the risk of loss or damage during shipment and transportation.

Pan American Health Organization lists the appropriate cold chain storage temperature for packaging of vaccines. Increasing adoption of cold chain packaging in healthcare, clinical research, vaccine packaging, and biopharma industry is shaping the market growth.

Pharmaceutical Cold Chain Packaging Market Download Report Brochure

With sudden outbreak of COVID-19, the demand for pharmaceutical cold chain packaging increased and it will continue to rise through the forecast period. Technological advancements and focus towards improving the performance of packaging formats are expected to further shape the market dynamics over the forecast period.

How is Increasing Vaccine Packaging Affecting the Growth of Pharmaceutical Cold Chain Packaging Market?

Due to outbreak of COVID-19 extensive investment in clinical research was observed across the globe during FQ-20. After the roll out of COVID-19 antidote in 2021, demand in the pharmaceutical cold chain packaging market has remarkably increased.

According to the United States International Trade Commission, mRNA based formulas should be stored at 80 °C. Almost 5% to 20% of the vaccines are lost during transportation. To avoid this, focus on efficient packaging and storage has increased, which is expected to create opportunities for pharmaceutical cold chain packaging market expansion.

How is Increasing Adoption of Vacuum Insulated Panels Propelling the Market Growth?

Rising demand for better handling of temperature sensitive pharmaceutical products has resulted in increased research for advanced cold chain packaging insulation solutions such as VIP (vacuum insulated panels).

According to Sofrigam, vacuum insulated panels can provide packaging support of 7 to 10 days, or even 2 to 3 times more than many insulation materials.

VIP-based insulation offers various advantages compared to polyurethane and expanded polystyrene insulated shippers. Shippers implementing VIP are comparatively smaller and lighter in weight, reduces refrigerant requirement, provide wide temperature range, and consecutively reduces distribution costs.

Due to this wide-array of benefits, key players are increasing the adoption of VIP in cold chain packaging.

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How will Technological Advancements Affect Pharmaceutical Cold Chain Packaging Market?

Real-time tracking, radio frequency identification (RFID) tagging, and adoption of cutting edge technologies are creating opportunities for market growth. Adoption of advanced technology such as internet of thinking (IoT), block-chain, advanced analytics, and integrated customer applications in pharmaceutical cold chain packaging is reshaping the market dynamics.

Cloud-based data management applications for better decision making, adhering to the regulatory norms and transparency are slowly becoming the new normal in the cold chain. Integration of digitalization and penetration of e-commerce platforms are further fueling the market growth.

Why are Manufacturers Shifting to Paper as Key Material in Pharmaceutical Cold Chain Packaging?

There is increasing pressure on pharmaceutical cold chain packaging producers to offer more sustainable solutions. Several attempts are made by packaging manufacturers to shift from polymer to eco-friendlier alternatives.

Several authorities and government bodies are compelling manufacturers to reduce their carbon footprint and move towards a sustainable packaging solutions. This is encouraging the adoption of paper in pharmaceutical cold chain packaging.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

How is Outsourcing Shaping the Pharmaceutical Cold Chain Packaging Market?

Leading pharmaceutical and healthcare manufacturers are outsourcing their logistics and distribution functions. A majority of manufacturers are opting for raw material sourcing, distribution, freight, warehousing, shipping and logistics function to be outsourced to a vendor.

Hence, adoption of 3PL or third party logistics has increased among the pharmaceutical companies. Adoption of 3PL reduces shipping costs and results in distribution of revenue and maintains a simpler supply chain.

Many other third-parties such as insurance providers, logistics providers, wholesalers/distributors, and control agencies are involved in the pharmaceutical cold chain packaging market. Outsourcing is slowly bringing a revolution in the pharmaceutical cold chain packaging market. Thereby, boosting market growth.

What is the Impact of COVID-19 on the Pharmaceutical Cold Chain Packaging Market?

Following the outbreak of COVID-19 in the first quarter of 2020, demand for surgical kits, diagnostic products, and blood products skyrocketed. Although, restricted air travel and ground transportation negatively impacted the market, thanks to the roll out of COVID-19 vaccines, demand for injectable increased around the world.

With increasing demand across Germany, India, China, and the U.S., pharmaceutical cold chain packaging market is rapidly recovering and is expected to witness high growth through 2031.

Country-Wise Insights

Why is the U.S. Dominating the Pharmaceutical Cold Chain Packaging Market?

The U.S. is home to many leading pharmaceutical and healthcare organizations. It is also one of the leading markets for temperature-sensitive healthcare products, vaccine packaging and clinical research materials.

The U.S. also provides supportive business environment for growth with minimum market barriers. Due to the presence of leading pharmaceutical companies across the country, the pharmaceutical cold chain market is expected to witness boost during the forecast period.

Besides this, technological advancements and innovation in the field of cold chain packaging will aid the market growth. According to the U.S. International Trade Administration, a significant change was observed in pharmaceutical cold chain packaging market in recent years when the shipment mode was changed from air transportation to sea modes. The sole reason behind this transition was temperature difference that led to deterioration of pharmaceutical products.

This change is anticipated to influence the market growth across the country. As per Future Market Insights, the U.S. pharmaceutical cold chain packaging market is poised to expand at an exceptional CAGR of over 11.2% through 2031.

Why is Germany Considered a Highly Lucrative Market for Pharmaceutical Cold China Packaging?

According to Germany Trade and Invest (GTAI), Germany is the largest pharmaceutical market in Europe with 12.5% of total revenue invested in R&D in 2018. With increasing investment in research and development activities, Germany has emerged as a key producer of cutting-edge innovative products.

As per FMI, Germany accounts for the largest share in the Europe cold chain packaging market. Sales of pharmaceutical cold chain packaging market across Germany are expected to rise at nearly 10.9% CAGR during the forecast period.

Germany also represents Europe’s most populous country. With access to skilled labor and technological advancements in the country, the market is expected to witness impressive growth.

Why is India Considered a Lucrative Market in South Asia?

As per Future Market Insights, India is expected to be the most lucrative market across South Asia. Exhibiting growth at over 14.7% CAGR, India’s pharmaceutical cold chain packaging market will witness high growth during the projection period.

Despite the outbreak of COVID-19, the market for cold chain observed positive growth. Development in the cold chain process and better infrastructure across the country will improve the market growth.

Backed by the favorable government policies for its manufacturing and logistics industry, India is expected to attract leading pharmaceutical manufacturers for its significant gap in the logistics and delivery market.

Government of India is widely promoting cold chain packaging in the country, it has launched various schemes and subsidies for cold chains logistics in the country. Some of it are low interest loans from warehousing infrastructure fund (NABARD), 100% FDI through the automatic approval rule, etc.

Will China Lead the East Asia Pharmaceutical Cold Chain Packaging Market?

China is considered to be the Asian hub for manufacturing and supply-chain. The number of 3PLs or third party logistic companies have rapidly increased over the past five years, giving a boost to pharmaceutical cold chain packaging market.

Investors and pharmaceutical manufacturing companies are constantly eyeing the China market due to its large customer size, low cost of shipping and presence of a large vendor base. Consumer’s preference for better healthcare, safety, and pharmaceutical packaging is helping the cold chain market to improve in the country.

The China’s pharmaceutical cold chain packaging market will exhibit highest growth across East Asia, registering nearly 17.8% CAGR by 2031-end.

Category-Wise Insights

How will Demand for Large Sized Pallet Containers Improve the Sales?

Large sized pallet containers are heavy duty containers and can carry up to 2,000 lbs. of load. Also, these containers can be reused and recycled which makes them a sustainable packaging option. The market for large sized pallet containers is expected to expand at a CAGR of 16.6% during the forecast period.

Large sized pallet containers contributes nearly 55.5% of global revenue in 2021 and is expected to reach US$ 30.0 Bn by 2031.

Why are Manufacturers Preferring Passive Packaging over Active Packaging?

Passive packaging format is expected to reach a market value of US$ 8.0 Bn in 2021 and register growth at over 14.3% CAGR. Its sub segment multi-use or reusable packaging segment is projected to grow by 4.4x during the forecast period.

Adding data loggers to passive packaging helps in better monitoring of goods and will boost the sales of the market. Packaging and logistics sustainability is the primary reason for the growth of segment in the market.

How is Increasing Application in Pharmaceutical Industry Spurring Sales?

In terms of end-use, the market is segmented into diagnostic centers, clinical research organization, blood banks, vaccines packaging industry, pharmaceuticals and other end-use industries.

As per FMI, demand in the pharmaceutical industry is expected to reach over US$ 12.4 Bn in 2031. Demand for pharmaceutical cold chain packaging in vaccine packaging and logistics is expected to increase exponentially due to increasing demand following the outbreak of COVID-19 across the globe.

Which Application will Create Maximum Incremental Opportunity by 2031?

Vaccine packaging segment is expected to generate an opportunity of US$ 16.6 Bn by 2031. Increasing demand for vaccines due to COVID-19 is a major driver for the vaccine packaging market.

Competitive Landscape

Leading manufacturers in the pharmaceutical cold chain packaging market are involved in new product development, partnerships, and investment in advanced technology to reduce packaging prices and improve their market share.

  • In August 2021, Sonoco Thermosafe announced a partnership with Korean Air, one of the largest airline and carrier based in South Korea to lease the newest shipping container temperature controlled Pegasus ULD®.
  • In February 2021, Pelican Products started distributing temperature-controlled cases for COVID-19 vaccine transportation.

Scope of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2015-2020

Market Analysis

US$ Million for Value, 000’ Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, BENELUX, Russia, Nordics, Russia, Poland, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa.

Key Segments Covered

Packaging Format,  Product, Material, Application, End Use, and Region

Key Companies Profiled

  • Sonoco ThermoSafe
  • Cold Chain Technologies
  • Sealed Air Corporation
  • Nordic Cold Chain Solutions
  • Cryopak
  • CSafe Global LLC
  • TemperPack Technologies, Inc.
  • Insulated Product Corp.
  • Global Cooling, Inc.
  • Envirotainer AB
  • va-Q-tec AG
  • EMBALL'ISO
  • Softbox Systems
  • Sofrigam SAS
  • DGP Intelsius LLC
  • Tempack Packaging Solutions SL
  • TOWER Cold Chain Solutions
  • Pelican BioThermal LLC
  • Blue Star Limited
  • BIOBASE Group
  • Andores New Energy Co., Ltd.
  • Haier Biomedical Co. Ltd.
  • Tamai Kasei Co., Ltd.
  • Dhruvraj Syndicate
  • Valor Industries
  • KODIAKOOLER
  • WoolCool Ltd.
  • Allwin Roto Plast

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Pharmaceutical Cold Chain Packaging Market by Category

By Packaging Format:

  • Passive Packaging
    • Single Use or One Way Use Packaging
    • Multiple Use or Re-Usable Packaging
  • Active Packaging
    • Reefer Trucks and Containers
    • Active Pallet Containers

By Product:

  • Small Boxes
  • Pallets
    • Single Pallets
    • Double Pallets
  • Large sized Pallet Containers

By Material:

  • Polymer
    • Polyethylene
    • Polypropylene
    • PET
    • EPS
    • Polyurethane
    • Others
  • Metal
  • Paper

By Application:

  • Biologics and Biological Samples
  • Vaccines and Diagnostics
  • Others

By End-Use:

  • Diagnostic Centers
  • Clinical Research Organization
  • Blood Banks
  • Vaccines Packaging Industry
  • Pharmaceuticals
  • Other Healthcare Units

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global pharmaceutical cold chain packaging market is expected to surpass US$ 11.7 Bn in 2021.

Vaccine and diagnostics is expected to hold over 44.1% of the value market share in 2021.

East Asia is expected to dominate the market, exhibiting growth at an impressive CAGR of 18.6% during the forecast period.

Vaccine packaging industry is expected to register maximum incremental opportunity in the next ten years.

Active packaging is expected to foresee a peak Y-o-Y growth rate of 16.4% in 2031.

The global pharmaceutical cold chain packaging market will exhibit growth at 13.5% in terms of volume.

The U.S. leads the North America pharmaceutical cold chain packaging market. The U.S. market is estimated reach a valuation of US$ 2.2 Bn in 2021.

China is expected to create an incremental opportunity of US$ 5.5 Bn during the forecast period.

The pharmaceutical cold chain packaging market exhibited growth at 12.5% CAGR between 2021 and 2031.

The demand for pharmaceutical cold chain packaging is expected to rise at 20.6% CAGR and 17.1% CAGR, respectively in Japan and South Korea between 2021 and 2031.

Table of Content

1. Executive Summary

    1.1. Global Market Overview

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Definition

    2.2. Market Taxonomy 

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

5. Global Pharmaceutical Cold Chain Packaging Market Demand Analysis 2015-2020 and Forecast, 2021-2031

    5.1. Historical Market Volume (‘000 Units) Analysis, 2015-2020

    5.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031

    5.3. Y-o-Y Growth Trend Analysis

6. Global Pharmaceutical Cold Chain Packaging Market - Pricing Analysis

    6.1. Regional Pricing Analysis, by Material

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Pharmaceutical Cold Chain Packaging Market Demand (US$ Mn) Analysis 2015-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Global Packaging Market Overview

    8.2. Global Plastic Packaging Market Overview

    8.3. Global Rigid Packaging Market Outlook

    8.4. Global Pharmaceutical Packaging Market Outlook

    8.5. Global Healthcare Expenditure Outlook, for Key Region

    8.6. Global Market Overview as per API, Part Finished, Finished Goods

    8.7. Global Market Overview as per 3PL, Clinical Specialist Logistics, Airlines, Pharmaceutical Company, Contract Manufacturer, Clinical Trial Provider

    8.8. Macro-Economic Factors & Co-relation Analysis

        8.8.1. Global GDP 

        8.8.2. GDP Per Capita

        8.8.3. Manufacturing Value Added

        8.8.4. Rigid Packaging Industry

        8.8.5. Packaging Industry

    8.9. Forecast Factors - Relevance & Impact

        8.9.1. GDP Growth

        8.9.2. Segmental Revenue Growth of Key Players

        8.9.3. Manufacturing Value Added Growth

        8.9.4. Rigid Packaging Industry Growth

        8.9.5. Packaging Industry Growth

    8.10.  Value Chain Analysis

        8.10.1. Key Market Participants

            8.10.1.1. Raw Material Suppliers

            8.10.1.2. Pharmaceutical Cold Chain Packaging Manufacturers

            8.10.1.3. End-users

        8.10.2. Profitability Margin

    8.11. Market Dynamics

        8.11.1. Drivers

        8.11.2. Restraints

        8.11.3. Opportunity Analysis

    8.12. Impact of COVID-19

        8.12.1. Current Statistics and Probable Future Impact

        8.12.2. Impact of COVID-19 on Pharmaceutical Cold Chain Packaging Market

9. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Packaging Format

    9.1. Introduction 

    9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by Packaging Format, 2015-2020

    9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by Packaging Format, 2021-2031

        9.3.1. Passive Packaging

            9.3.1.1. Single Use or One Way Use Packaging

            9.3.1.2. Multiple Use or Re-Usable Packaging

        9.3.2. Active Packaging

            9.3.2.1. Reefer Trucks and Containers

            9.3.2.2. Active Pallet Containers

    9.4. Market Attractiveness Analysis, by Packaging Format 

10. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Product

    10.1. Introduction 

    10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by Product, 2015-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by Product, 2021-2031

        10.3.1. Small Boxes

        10.3.2. Pallets

            10.3.2.1. Single Pallets

            10.3.2.2. Double Pallets

        10.3.3. Large Sized Pallet Containers 

    10.4. Market Attractiveness Analysis, by Product

11. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, By Material

    11.1. Introduction 

    11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by Material, 2015-2020

    11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by Material, 2021-2031

        11.3.1. Polymer

            11.3.1.1. Polyethylene

            11.3.1.2. Polypropylene

            11.3.1.3. PET

            11.3.1.4. EPS

            11.3.1.5. Polyurethane

            11.3.1.6. Others

        11.3.2. Metal

        11.3.3. Paper

    11.4. Market Attractiveness Analysis, by Material

12. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Application

    12.1. Introduction 

    12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by Application, 2015-2020

    12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by Application, 2021-2031

        12.3.1. Biologics and Biological Samples

        12.3.2. Vaccines and Diagnostics 

        12.3.3. Others

    12.4. Market Attractiveness Analysis, by Application

13. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by End Use

    13.1. Introduction 

    13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by End Use, 2015-2020

    13.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by End Use, 2021-2031

        13.3.1. Diagnostic Centres

        13.3.2. Clinical Research Organization

        13.3.3. Blood Banks

        13.3.4. Vaccines Packaging Industry

        13.3.5. Pharmaceuticals

        13.3.6. Other Healthcare Units 

    13.4. Market Attractiveness Analysis, by End Use

14. Global Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031, by Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis, by Region, 2015-2020

    14.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast, by Region, 2021-2031

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. Middle East and Africa (MEA)

        14.3.5. East Asia

        14.3.6. South Asia

        14.3.7. Oceania

    14.4. Market Attractiveness Analysis, by Region

15. North America Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    15.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Packaging Format

        15.3.3. By Product

        15.3.4. By Material

        15.3.5. By Application

        15.3.6. By End Use

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Packaging Format

        15.4.3. By Product

        15.4.4. By Material

        15.4.5. By Application

        15.4.6. By End Use

16. Latin America Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    16.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        16.3.1.  By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Packaging Format

        16.3.3. By Product

        16.3.4. By Material

        16.3.5. By Application

        16.3.6. By End Use

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Packaging Format

        16.4.3. By Product

        16.4.4. By Material

        16.4.5. By Application

        16.4.6. By End Use

17. Europe Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    17.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        17.3.1.  By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Nordics

            17.3.1.8. Russia

            17.3.1.9. Poland

            17.3.1.10. Rest of Europe

        17.3.2. By Packaging Format

        17.3.3. By Product

        17.3.4. By Material

        17.3.5. By Application

        17.3.6. By End Use

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Packaging Format

        17.4.3. By Product

        17.4.4. By Material

        17.4.5. By Application

        17.4.6. By End Use

18. South Asia Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    18.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        18.3.1.  By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Packaging Format

        18.3.3. By Product

        18.3.4. By Material

        18.3.5. By Application

        18.3.6. By End Use

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Packaging Format

        18.4.3. By Product

        18.4.4. By Material

        18.4.5. By Application

        18.4.6. By End Use

19. East Asia Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    19.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        19.3.1.  By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Packaging Format

        19.3.3. By Product

        19.3.4. By Material

        19.3.5. By Application

        19.3.6. By End Use

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Packaging Format

        19.4.3. By Product

        19.4.4. By Material

        19.4.5. By Application

        19.4.6. By End Use

20. Oceania Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    20.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        20.3.1.  By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Packaging Format

        20.3.3. By Product

        20.3.4. By Material

        20.3.5. By Application

        20.3.6. By End Use

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Packaging Format

        20.4.3. By Product

        20.4.4. By Material

        20.4.5. By Application

        20.4.6. By End Use

21. Middle East and Africa Pharmaceutical Cold Chain Packaging Market Analysis 2015-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Trend Analysis, by Market Taxonomy, 2015-2020

    21.3. Market Size (US$ Mn) and Volume (‘000 Units) Forecast, by Market Taxonomy, 2021-2031

        21.3.1.  By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Turkey

            21.3.1.3. Northern Africa

            21.3.1.4. South Africa

            21.3.1.5. Rest of Middle East and Africa

        21.3.2. By Packaging Format

        21.3.3. By Product

        21.3.4. By Material

        21.3.5. By Application

        21.3.6. By End Use

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Packaging Format

        21.4.3. By Product

        21.4.4. By Material

        21.4.5. By Application

        21.4.6. By End Use

22. Pharmaceutical Cold Chain Packaging Market Country-wise Analysis and Forecast 

    22.1. U.S. Pharmaceutical Cold Chain Packaging Market Analysis 2021 & 2031

        22.1.1. Market Volume (‘000 Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            22.1.1.1. By Packaging Format

            22.1.1.2. By Product

            22.1.1.3. By Material

            22.1.1.4. By Application

            22.1.1.5. By End Use

    22.2. Brazil Pharmaceutical Cold Chain Packaging Market Analysis 2021 & 2031

        22.2.1. Market Volume (‘000 Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            22.2.1.1. By Packaging Format

            22.2.1.2. By Product

            22.2.1.3. By Material

            22.2.1.4. By Application

            22.2.1.5. By End Use

    22.3. Germany Pharmaceutical Cold Chain Packaging Market Analysis 2021 & 2031

        22.3.1. Market Volume (‘000 Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            22.3.1.1. By Packaging Format

            22.3.1.2. By Product

            22.3.1.3. By Material

            22.3.1.4. By Application

            22.3.1.5. By End Use

    22.4. GCC Countries Pharmaceutical Cold Chain Packaging Market Analysis 2021 & 2031

        22.4.1. Market Volume (‘000 Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            22.4.1.1. By Packaging Format

            22.4.1.2. By Product

            22.4.1.3. By Material

            22.4.1.4. By Application

            22.4.1.5. By End Use

    22.5. India Pharmaceutical Cold Chain Packaging Market Analysis 2021 & 2031

        22.5.1. Market Volume (‘000 Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            22.5.1.1. By Packaging Format

            22.5.1.2. By Product

            22.5.1.3. By Material

            22.5.1.4. By Application

            22.5.1.5. By End Use

23. Market Structure Analysis

    23.1. Market Analysis, by Tier of Pharmaceutical Cold Chain Packaging Companies 

    23.2. Market Share Analysis of Top Players

    23.3. Market Presence Analysis

        23.3.1. By Regional footprint of Players

        23.3.2. Product foot print by Players

        23.3.3. Channel Foot Print by Players

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Competition Benchmarking

    24.3. Competition Deep Dive 

        24.3.1. Global Players

            24.3.1.1. Sonoco ThermoSafe

                24.3.1.1.1. Overview

                24.3.1.1.2. Product Portfolio

                24.3.1.1.3. Profitability by Market Segments

                24.3.1.1.4. Sales Footprint

                24.3.1.1.5. Strategy Overview

                    24.3.1.1.5.1. Marketing Strategy

                    24.3.1.1.5.2. Product Strategy

                    24.3.1.1.5.3. Channel Strategy

            24.3.1.2. Cold Chain Technologies

                24.3.1.2.1. Overview

                24.3.1.2.2. Product Portfolio

                24.3.1.2.3. Profitability by Market Segments

                24.3.1.2.4. Sales Footprint

                24.3.1.2.5. Strategy Overview

                    24.3.1.2.5.1. Marketing Strategy

                    24.3.1.2.5.2. Product Strategy

                    24.3.1.2.5.3. Channel Strategy

            24.3.1.3. Sealed Air Corporation

                24.3.1.3.1. Overview

                24.3.1.3.2. Product Portfolio

                24.3.1.3.3. Profitability by Market Segments

                24.3.1.3.4. Sales Footprint

                24.3.1.3.5. Strategy Overview

                    24.3.1.3.5.1. Marketing Strategy

                    24.3.1.3.5.2. Product Strategy

                    24.3.1.3.5.3. Channel Strategy

            24.3.1.4. Nordic Cold Chain Solutions

                24.3.1.4.1. Overview

                24.3.1.4.2. Product Portfolio

                24.3.1.4.3. Profitability by Market Segments

                24.3.1.4.4. Sales Footprint

                24.3.1.4.5. Strategy Overview

                    24.3.1.4.5.1. Marketing Strategy

                    24.3.1.4.5.2. Product Strategy

                    24.3.1.4.5.3. Channel Strategy

            24.3.1.5. Cryopak

                24.3.1.5.1. Overview

                24.3.1.5.2. Product Portfolio

                24.3.1.5.3. Profitability by Market Segments

                24.3.1.5.4. Sales Footprint

                24.3.1.5.5. Strategy Overview

                    24.3.1.5.5.1. Marketing Strategy

                    24.3.1.5.5.2. Product Strategy

                    24.3.1.5.5.3. Channel Strategy

            24.3.1.6. CSafe Global LLC

                24.3.1.6.1. Overview

                24.3.1.6.2. Product Portfolio

                24.3.1.6.3. Profitability by Market Segments

                24.3.1.6.4. Sales Footprint

                24.3.1.6.5. Strategy Overview

                    24.3.1.6.5.1. Marketing Strategy

                    24.3.1.6.5.2. Product Strategy

                    24.3.1.6.5.3. Channel Strategy

            24.3.1.7. TemperPack Technologies, Inc.

                24.3.1.7.1. Overview

                24.3.1.7.2. Product Portfolio

                24.3.1.7.3. Profitability by Market Segments

                24.3.1.7.4. Sales Footprint

                24.3.1.7.5. Strategy Overview

                    24.3.1.7.5.1. Marketing Strategy

                    24.3.1.7.5.2. Product Strategy

                    24.3.1.7.5.3. Channel Strategy

            24.3.1.8. Insulated Product Corp.

                24.3.1.8.1. Overview

                24.3.1.8.2. Product Portfolio

                24.3.1.8.3. Profitability by Market Segments

                24.3.1.8.4. Sales Footprint

                24.3.1.8.5. Strategy Overview

                    24.3.1.8.5.1. Marketing Strategy

                    24.3.1.8.5.2. Product Strategy

                    24.3.1.8.5.3. Channel Strategy

            24.3.1.9. Global Cooling, Inc.

                24.3.1.9.1. Overview

                24.3.1.9.2. Product Portfolio

                24.3.1.9.3. Profitability by Market Segments

                24.3.1.9.4. Sales Footprint

                24.3.1.9.5. Strategy Overview

                    24.3.1.9.5.1. Marketing Strategy

                    24.3.1.9.5.2. Product Strategy

                    24.3.1.9.5.3. Channel Strategy

            24.3.1.10. Envirotainer AB

                24.3.1.10.1. Overview

                24.3.1.10.2. Product Portfolio

                24.3.1.10.3. Profitability by Market Segments

                24.3.1.10.4. Sales Footprint

                24.3.1.10.5. Strategy Overview

                    24.3.1.10.5.1. Marketing Strategy

                    24.3.1.10.5.2. Product Strategy

                    24.3.1.10.5.3. Channel Strategy

            24.3.1.11. va-Q-tec AG

                24.3.1.11.1. Overview

                24.3.1.11.2. Product Portfolio

                24.3.1.11.3. Profitability by Market Segments

                24.3.1.11.4. Sales Footprint

                24.3.1.11.5. Strategy Overview

                    24.3.1.11.5.1. Marketing Strategy

                    24.3.1.11.5.2. Product Strategy

                    24.3.1.11.5.3. Channel Strategy

            24.3.1.12. EMBALL'ISO

                24.3.1.12.1. Overview

                24.3.1.12.2. Product Portfolio

                24.3.1.12.3. Profitability by Market Segments

                24.3.1.12.4. Sales Footprint

                24.3.1.12.5. Strategy Overview

                    24.3.1.12.5.1. Marketing Strategy

                    24.3.1.12.5.2. Product Strategy

                    24.3.1.12.5.3. Channel Strategy

            24.3.1.13. Softbox Systems

                24.3.1.13.1. Overview

                24.3.1.13.2. Product Portfolio

                24.3.1.13.3. Profitability by Market Segments

                24.3.1.13.4. Sales Footprint

                24.3.1.13.5. Strategy Overview

                    24.3.1.13.5.1. Marketing Strategy

                    24.3.1.13.5.2. Product Strategy

                    24.3.1.13.5.3. Channel Strategy

            24.3.1.14. Sofrigam SAS

                24.3.1.14.1. Overview

                24.3.1.14.2. Product Portfolio

                24.3.1.14.3. Profitability by Market Segments

                24.3.1.14.4. Sales Footprint

                24.3.1.14.5. Strategy Overview

                    24.3.1.14.5.1. Marketing Strategy

                    24.3.1.14.5.2. Product Strategy

                    24.3.1.14.5.3. Channel Strategy

            24.3.1.15. DGP Intelsius LLC

                24.3.1.15.1. Overview

                24.3.1.15.2. Product Portfolio

                24.3.1.15.3. Profitability by Market Segments

                24.3.1.15.4. Sales Footprint

                24.3.1.15.5. Strategy Overview

                    24.3.1.15.5.1. Marketing Strategy

                    24.3.1.15.5.2. Product Strategy

                    24.3.1.15.5.3. Channel Strategy

            24.3.1.16. Tempack Packaging Solutions SL

                24.3.1.16.1. Overview

                24.3.1.16.2. Product Portfolio

                24.3.1.16.3. Profitability by Market Segments

                24.3.1.16.4. Sales Footprint

                24.3.1.16.5. Strategy Overview

                    24.3.1.16.5.1. Marketing Strategy

                    24.3.1.16.5.2. Product Strategy

                    24.3.1.16.5.3. Channel Strategy

            24.3.1.17. TOWER Cold Chain Solutions

                24.3.1.17.1. Overview

                24.3.1.17.2. Product Portfolio

                24.3.1.17.3. Profitability by Market Segments

                24.3.1.17.4. Sales Footprint

                24.3.1.17.5. Strategy Overview

                    24.3.1.17.5.1. Marketing Strategy

                    24.3.1.17.5.2. Product Strategy

                    24.3.1.17.5.3. Channel Strategy

            24.3.1.18. Pelican BioThermal LLC

                24.3.1.18.1. Overview

                24.3.1.18.2. Product Portfolio

                24.3.1.18.3. Profitability by Market Segments

                24.3.1.18.4. Sales Footprint

                24.3.1.18.5. Strategy Overview

                    24.3.1.18.5.1. Marketing Strategy

                    24.3.1.18.5.2. Product Strategy

                    24.3.1.18.5.3. Channel Strategy

            24.3.1.19. Blue Star Limited

                24.3.1.19.1. Overview

                24.3.1.19.2. Product Portfolio

                24.3.1.19.3. Profitability by Market Segments

                24.3.1.19.4. Sales Footprint

                24.3.1.19.5. Strategy Overview

                    24.3.1.19.5.1. Marketing Strategy

                    24.3.1.19.5.2. Product Strategy

                    24.3.1.19.5.3. Channel Strategy

            24.3.1.20. BIOBASE Group 

                24.3.1.20.1. Overview

                24.3.1.20.2. Product Portfolio

                24.3.1.20.3. Profitability by Market Segments

                24.3.1.20.4. Sales Footprint

                24.3.1.20.5. Strategy Overview

                    24.3.1.20.5.1. Marketing Strategy

                    24.3.1.20.5.2. Product Strategy

                    24.3.1.20.5.3. Channel Strategy

            24.3.1.21. Andores New Energy Co., Ltd.

                24.3.1.21.1. Overview

                24.3.1.21.2. Product Portfolio

                24.3.1.21.3. Profitability by Market Segments

                24.3.1.21.4. Sales Footprint

                24.3.1.21.5. Strategy Overview

                    24.3.1.21.5.1. Marketing Strategy

                    24.3.1.21.5.2. Product Strategy

                    24.3.1.21.5.3. Channel Strategy

            24.3.1.22. Haier Biomedical Co. Ltd.

                24.3.1.22.1. Overview

                24.3.1.22.2. Product Portfolio

                24.3.1.22.3. Profitability by Market Segments

                24.3.1.22.4. Sales Footprint

                24.3.1.22.5. Strategy Overview

                    24.3.1.22.5.1. Marketing Strategy

                    24.3.1.22.5.2. Product Strategy

                    24.3.1.22.5.3. Channel Strategy

            24.3.1.23. Tamai Kasei Co., Ltd.

                24.3.1.23.1. Overview

                24.3.1.23.2. Product Portfolio

                24.3.1.23.3. Profitability by Market Segments

                24.3.1.23.4. Sales Footprint

                24.3.1.23.5. Strategy Overview

                    24.3.1.23.5.1. Marketing Strategy

                    24.3.1.23.5.2. Product Strategy

                    24.3.1.23.5.3. Channel Strategy

            24.3.1.24. Dhruvraj Syndicate

                24.3.1.24.1. Overview

                24.3.1.24.2. Product Portfolio

                24.3.1.24.3. Profitability by Market Segments

                24.3.1.24.4. Sales Footprint

                24.3.1.24.5. Strategy Overview

                    24.3.1.24.5.1. Marketing Strategy

                    24.3.1.24.5.2. Product Strategy

                    24.3.1.24.5.3. Channel Strategy

            24.3.1.25. Valor Industries

                24.3.1.25.1. Overview

                24.3.1.25.2. Product Portfolio

                24.3.1.25.3. Profitability by Market Segments

                24.3.1.25.4. Sales Footprint

                24.3.1.25.5. Strategy Overview

                    24.3.1.25.5.1. Marketing Strategy

                    24.3.1.25.5.2. Product Strategy

                    24.3.1.25.5.3. Channel Strategy

            24.3.1.26. KODIAKOOLER

                24.3.1.26.1. Overview

                24.3.1.26.2. Product Portfolio

                24.3.1.26.3. Profitability by Market Segments

                24.3.1.26.4. Sales Footprint

                24.3.1.26.5. Strategy Overview

                    24.3.1.26.5.1. Marketing Strategy

                    24.3.1.26.5.2. Product Strategy

                    24.3.1.26.5.3. Channel Strategy

            24.3.1.27. WoolCool Ltd.

                24.3.1.27.1. Overview

                24.3.1.27.2. Product Portfolio

                24.3.1.27.3. Profitability by Market Segments

                24.3.1.27.4. Sales Footprint

                24.3.1.27.5. Strategy Overview

                    24.3.1.27.5.1. Marketing Strategy

                    24.3.1.27.5.2. Product Strategy

                    24.3.1.27.5.3. Channel Strategy

            24.3.1.28. Allwin Roto Plast

                24.3.1.28.1. Overview

                24.3.1.28.2. Product Portfolio

                24.3.1.28.3. Profitability by Market Segments

                24.3.1.28.4. Sales Footprint

                24.3.1.28.5. Strategy Overview

                    24.3.1.28.5.1. Marketing Strategy

                    24.3.1.28.5.2. Product Strategy

                    24.3.1.28.5.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 02: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 03: Global Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 04: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 05: Global Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Global Pharmaceutical Cold Chain Packaging Market Analysis and Forecast, By Material

Table 06: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 07: Global Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 08: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 09: Global Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 10: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 11: Global Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Region, 2015(H)-2031(F)

Table 12: Global Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Region, 2015(H)-2031(F)

Table 13: North America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 14: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 15: North America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 16: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 17: North America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 18: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 19: North America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 20: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 21: North America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 22: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 23: North America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 24: North America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 25: Latin America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 26: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 27: Latin America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 28: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 29: Latin America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 30: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 31: Latin America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 32: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 33: Latin America Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 34: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 35: Latin America Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 36: Latin America Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 37: Europe Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 38: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 39: Europe Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 40: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 41: Europe Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 42: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 43: Europe Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 44: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 45: Europe Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 46: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 47: Europe Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 48: Europe Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 49: South Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 50: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 51: South Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 52: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 53: South Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 54: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 55: South Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 56: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 57: South Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 58: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 59: South Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 60: South Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 61: East Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 62: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 63: East Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 64: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 65: East Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 66: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 67: East Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 68: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 69: East Asia Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 70: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 71: East Asia Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 72: East Asia Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 73: Oceania Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 74: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 75: Oceania Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 76: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 77: Oceania Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 78: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 79: Oceania Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 80: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 81: Oceania Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 82: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 83: Oceania Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 84: Oceania Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 85: MEA Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 86: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Packaging Format, 2015(H)-2031(F)

Table 87: MEA Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 88: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Product, 2015(H)-2031(F)

Table 89: MEA Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 90: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Material, 2015(H)-2031(F)

Table 91: MEA Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 92: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Application, 2015(H)-2031(F)

Table 93: MEA Pharmaceutical Cold Chain Packaging Market Volume (‘000 Units) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 94: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By End Use, 2015(H)-2031(F)

Table 95: MEA Pharmaceutical Cold Chain Packaging Market Volume ('000 Units) Analysis and Forecast, By Country, 2015(H)-2031(F)

Table 96: MEA Pharmaceutical Cold Chain Packaging Market Value (US$ Mn) Analysis and Forecast, By Country, 2015(H)-2031(F)

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 02: Global Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Packaging Format, 2019(H)-2031(F)

Figure 03: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Packaging Format, 2021(E)-2031(F)

Figure 04: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 05: Global Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 06: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Product, 2021(E)-2031(F)

Figure 07: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 08: Global Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Material, 2019(H)-2031(F)

Figure 09: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 10: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 11: Global Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 12: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Application, 2021(E)-2031(F)

Figure 13: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 14: Global Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By End Use, 2019(H)-2031(F)

Figure 15: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By End Use, 2021(E)-2031(F)

Figure 16: Global Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Region, 2021(E)-2031(F)

Figure 17: Global Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Region, 2021(E) & 2031(F)

Figure 18: North America Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 19: North America Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 20: North America Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 21: North America Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 22: North America Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 23: North America Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 24: Latin America Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 25: Latin America Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 26: Latin America Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 27: Latin America Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 28: Latin America Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 29: Latin America Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 30: Europe Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 31: Europe Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 32: Europe Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 33: Europe Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 34: Europe Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 35: Europe Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 36: South Asia Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 37: South Asia Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 38: South Asia Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 39: South Asia Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 40: South Asia Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 41: South Asia Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 42: East Asia Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 43: East Asia Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 44: East Asia Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 45: East Asia Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 46: East Asia Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 47: East Asia Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 48: Oceania Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 49: Oceania Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 50: Oceania Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 51: Oceania Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 52: Oceania Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 53: Oceania Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 54: MEA Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 55: MEA Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Product, 2019(H)-2031(F)

Figure 56: MEA Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Material, 2021(E)-2031(F)

Figure 57: MEA Pharmaceutical Cold Chain Packaging Market Y-o-Y Analysis, By Application, 2019(H)-2031(F)

Figure 58: MEA Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 59: MEA Pharmaceutical Cold Chain Packaging Market Attractiveness Analysis, By Country, 2021(E)-2031(F)

Figure 60: U.S. Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 61: U.S. Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 62: U.S. Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 63: U.S. Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 64: U.S. Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 65: Brazil Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 66: Brazil Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 67: Brazil Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 68: Brazil Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 69: Brazil Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 70: Germany Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 71: Germany Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 72: Germany Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 73: Germany Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 74: Germany Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 75: GCC Countries Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 76: GCC Countries Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 77: GCC Countries Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 78: GCC Countries Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 79: GCC Countries Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Figure 80: India Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Packaging Format, 2021(E) & 2031(F)

Figure 81: India Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Product, 2021(E) & 2031(F)

Figure 82: India Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Material, 2021(E) & 2031(F)

Figure 83: India Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By Application, 2021(E) & 2031(F)

Figure 84: India Pharmaceutical Cold Chain Packaging Market Value Share Analysis, By End Use, 2021(E) & 2031(F)

Need specific information?

Request Customization

Explore Packaging Insights

View Reports
Google translate

Pharmaceutical Cold Chain Packaging Market